Patents by Inventor Michael Kershaw

Michael Kershaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150482
    Abstract: The present application is directed to bispecific polypeptides comprising a first domain binding an antigen on an antigen presenting cell (ARC) and a second domain binding an antigen on an immune cell expressing a chimeric antigen receptor (CAR). Nucleic acids, vectors and host cells used in producing the polypeptide of the invention are also disclosed. Compositions comprising the bispecific polypeptides and methods of treating cancer and stimulating activation and expansion of immune cells in vivo and in vitro are also disclosed.
    Type: Application
    Filed: November 13, 2023
    Publication date: May 9, 2024
    Applicant: Peter MacCallum Cancer Institute
    Inventors: Michael Kershaw, Clare Slaney, Bianca Von Scheidt
  • Publication number: 20240101638
    Abstract: The invention relates to a chimeric antigen receptor (CAR) that binds to mesothelin and cells that express the CAR, as well as uses thereof for the treatment of cancer.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 28, 2024
    Applicant: Currus Biologics Pty Ltd
    Inventors: Samantha Cobb, Michael Kershaw, Clare Slaney
  • Patent number: 11866504
    Abstract: The present application is directed to bispecific polypeptides comprising a first domain binding an antigen on an antigen presenting cell (ARC) and a second domain binding an antigen on an immune cell expressing a chimeric antigen receptor (CAR). Nucleic acids, vectors and host cells used in producing the polypeptide of the invention are also disclosed. Compositions comprising the bispecific polypeptides and methods of treating cancer and stimulating activation and expansion of immune cells in vivo and in vitro are also disclosed.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: January 9, 2024
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Michael Kershaw, Clare Slaney, Bianca Von Scheidt
  • Publication number: 20220017628
    Abstract: The present application is directed to bispecific polypeptides comprising a first domain binding an antigen on an antigen presenting cell (ARC) and a second domain binding an antigen on an immune cell expressing a chimeric antigen receptor (CAR). Nucleic acids, vectors and host cells used in producing the polypeptide of the invention are also disclosed. Compositions comprising the bispecific polypeptides and methods of treating cancer and stimulating activation and expansion of immune cells in vivo and in vitro are also disclosed.
    Type: Application
    Filed: October 29, 2019
    Publication date: January 20, 2022
    Applicant: Peter MacCallum Cancer Institute
    Inventors: Michael Kershaw, Clare Slaney, Bianca Von Scheidt
  • Patent number: 8647142
    Abstract: A retainer comprises at least two retaining straps or retainer screws and a retainer plate having a cord hole, a slot, and a plurality of retainer holes or retainer strap notches. The retainer maintains connection of an electrical power plug at an end of an electrical power cord to an electrical power receptacle when the retainer is installed. The cord hole and slot extend through the retainer plate, and the slot extends from an edge of the retainer plate to the cord hole. Each of the at least two retaining straps is operable to engage a retainer hole or retaining strap notch in the retainer plate and extend from the retainer plate around the electrical power receptacle and back to the retainer plate.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: February 11, 2014
    Inventor: David Michael Kershaw